Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared With Ertapenem in Complicated Urinary Tract Infections

NCT03032510 is registered in ClinicalTrials.gov with Tetraphase Pharmaceuticals, Inc as lead sponsor.

NCT NCT03032510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03032510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared With Ertapenem in Complicated Urinary Tract Infections
Lead sponsor
Tetraphase Pharmaceuticals, Inc
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2017
Completion date
January 31, 2018
Enrollment
1,205 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

complicated urinary tract infections